Cargando…

Platelet-Activating Factor (PAF) in Allergic Rhinitis: Clinical and Therapeutic Implications

Platelet-activating factor (PAF) is a lipid mediator involved in several allergic reactions. It is released from multiple cells of the immune system, such as eosinophils, neutrophils, and mast cells, and also exerts its effect on most of them upon specific binding to its receptor, becoming a pleiotr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muñoz-Cano, Rosa M., Casas-Saucedo, Rocio, Valero Santiago, Antonio, Bobolea, Irina, Ribó, Paula, Mullol, Joaquim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780525/ https://www.ncbi.nlm.nih.gov/pubmed/31470575 http://dx.doi.org/10.3390/jcm8091338

Ejemplares similares

Evaluation of nasal symptoms induced by platelet activating factor, after nasal challenge in both healthy and allergic rhinitis subjects pretreated with rupatadine, levocetirizine or placebo in a cross-over study design
por: Muñoz-Cano, Rosa, et al.
Publicado: (2013)

Management of persistent allergic rhinitis: evidence-based treatment with levocetirizine
por: Mullol, Joaquim, et al.
Publicado: (2005)

Severity of allergic rhinitis impacts sleep and anxiety: results from a large Spanish cohort
por: Muñoz-Cano, R., et al.
Publicado: (2018)

Measuring outcomes in allergic rhinitis: psychometric characteristics of a Spanish version of the congestion quantifier seven-item test (CQ7)
por: Valero, Antonio, et al.
Publicado: (2011)

Clinically relevant effect of rupatadine 20 mg and 10 mg in seasonal allergic rhinitis: a pooled responder analysis
por: Mullol, Joaquim, et al.
Publicado: (2019)

Higher efficacy of rupatadine 20 mg and 10 mg versus placebo in patients with perennial allergic rhinitis: a pooled responder analysis
por: Valero, Antonio, et al.
Publicado: (2020)

Allergic rhinitis and asthma symptoms in a real-life study of MP-AzeFlu to treat multimorbid allergic rhinitis and asthma
por: Price, David, et al.
Publicado: (2020)

Patient Perceptions of Allergic Rhinitis and Quality of Life: Findings From a Survey Conducted in Europe and the United States
por: Canonica, G Walter, et al.
Publicado: (2008)

Chronic rhinosinusitis with nasal polyps and allergic rhinitis as different multimorbid treatable traits in asthma
por: Castillo, José Antonio, et al.
Publicado: (2023)

The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey
por: Price, David, et al.
Publicado: (2015)

MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis
por: van Weissenbruch, Ranny, et al.
Publicado: (2020)

PAF‐induced inflammatory and immuno‐allergic ophthalmic diseases and their mitigation with PAF receptor antagonists: Cell and nuclear effects
por: Sharif, Najam A.
Publicado: (2022)

Therapeutic effects of intranasal tocotrienol-rich fraction on rhinitis symptoms in platelet-activating factor induced allergic rhinitis
por: Teo, Cheryl Wei Ling, et al.
Publicado: (2022)

Effect of sublingual immunotherapy on platelet activity in children with allergic rhinitis()
por: Chen, Yanqiu, et al.
Publicado: (2016)

Dual systemic allergic rhinitis and local allergic rhinitis
por: Blanca, Miguel, et al.
Publicado: (2015)

Platelet activating factor-induced mast cell degranulation is inhibited by rupatadine, and to a lower extent by levocetirizine and desoratadine, in a mast cell line (LAD-2)
por: Mullol, Joaquim, et al.
Publicado: (2013)

Allergic rhinitis
por: Small, Peter, et al.
Publicado: (2011)

Allergic rhinitis
por: Small, Peter, et al.
Publicado: (2018)

A new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch
por: Fokkens, Wytske, et al.
Publicado: (2015)

Management of allergic rhinitis symptoms in the pharmacy Pocket guide 2022
por: Lourenço, Olga, et al.
Publicado: (2022)

Is platelet activating factor (PAF) an important mediator in bronchial asthma?
por: Gundel, R. H., et al.
Publicado: (1992)

Update about Oralair® as a treatment for grass pollen allergic rhinitis
por: Klimek, L., et al.
Publicado: (2022)

Differences in Inflammatory Cytokine Profile in Obesity-Associated Asthma: Effects of Weight Loss
por: Bantulà, Marina, et al.
Publicado: (2022)

NOVEL THERAPEUTIC APPROACHES FOR ALLERGIC RHINITIS
por: Agosti, Jan M., et al.
Publicado: (2000)

Management of Rhinitis: Allergic and Non-Allergic
por: Tran, Nguyen P, et al.
Publicado: (2011)

IV Brazilian Consensus on Rhinitis – an update on allergic rhinitis()()
por: Sakano, Eulalia, et al.
Publicado: (2017)

The association of allergic rhinitis severity with neutrophil-lymphocyte and platelet-lymphocyte ratio in children
por: Cansever, Murat, et al.
Publicado: (2022)

Modulation of Tumor-Associated Macrophages (TAM) Phenotype by Platelet-Activating Factor (PAF) Receptor
por: da Silva Junior, Ildefonso Alves, et al.
Publicado: (2017)

Management of allergic rhinitis
por: Solelhac, Geoffroy, et al.
Publicado: (2014)

Acute allergic rhinitis
por: Green, Robin J., et al.
Publicado: (2020)

Probiotics in allergic rhinitis
por: Nogueira, Janaina Cândida Rodrigues, et al.
Publicado: (2015)

Local allergic rhinitis()
por: Mello Junior, João Ferreira de
Publicado: (2016)

Microbial characterization of the nasal cavity in patients with allergic rhinitis and non-allergic rhinitis
por: Che, Yanlu, et al.
Publicado: (2023)

Interaction between PAF and human platelet membranes: a fluorescence study
por: Kantar, Ahmad, et al.
Publicado: (1992)

Impact of the Allergic Therapeutic Adherence in Children with Allergic Rhinitis and ADHD: A Pilot Study
por: Gambadauro, Antonella, et al.
Publicado: (2023)

Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak
por: Rial, Manuel Jorge, et al.
Publicado: (2021)

Validation of the DECA criteria for allergic conjunctivitis severity and control
por: Sánchez-Hernández, M. Cesárea, et al.
Publicado: (2020)

Self-assessment of Allergic Rhinitis and Asthma (SACRA) Questionnaire-based Allergic Rhinitis Treatment Improves Asthma Control in Asthmatic Patients with Allergic Rhinitis
por: Yasuo, Masanori, et al.
Publicado: (2017)

A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress
por: Hellings, Peter W., et al.
Publicado: (2015)

Recognition of allergic conjunctivitis in patients with allergic rhinitis
por: Williams, Daniel C, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7qldj5cpeo3cp32036j8oaba85